Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

Showing session: reset

Differentiation Syndrome in Acute Myeloid Leukemia: Challenges for Drug Development and Regulation

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 6 of 6
Differentiation Syndrome in Acute Myeloid Leukemia: Challenges for Drug Development and Regulation
Introduction
Kelly J Norsworthy
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2019 on April 1, 2019 1:00 PM-2:45 PM
Differentiation Syndrome in Acute Myeloid Leukemia: Challenges for Drug Development and Regulation
Introduction
E. Dianne Pulte
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2019 on April 1, 2019 1:00 PM-2:45 PM
Differentiation Syndrome in Acute Myeloid Leukemia: Challenges for Drug Development and Regulation
Invited Speaker
Mark J. Levis
Johns Hopkins Sidney Kimmel Cancer Center, Baltimore, MD, United States
from AACR Annual Meeting 2019 on April 1, 2019 1:00 PM-2:45 PM
Differentiation Syndrome in Acute Myeloid Leukemia: Challenges for Drug Development and Regulation
Invited Speaker
Feng Wang
UT MD Anderson Cancer Center, Houston, TX, United States
from AACR Annual Meeting 2019 on April 1, 2019 1:00 PM-2:45 PM
Differentiation Syndrome in Acute Myeloid Leukemia: Challenges for Drug Development and Regulation
Invited Speaker
B. Douglas Smith
Johns Hopkins Univ. School of Medicine, Baltimore, MD, United States
Jessica K. Altman
Northwestern Medicine, Chicago, IL, United States
from AACR Annual Meeting 2019 on April 1, 2019 1:00 PM-2:45 PM
Differentiation Syndrome in Acute Myeloid Leukemia: Challenges for Drug Development and Regulation
Panel Discussion
E. Dianne Pulte
U.S. Food and Drug Administration, Silver Spring, MD, United States
B. Douglas Smith
Johns Hopkins Univ. School of Medicine, Baltimore, MD, United States
Kelly J Norsworthy
U.S. Food and Drug Administration, Silver Spring, MD, United States
Mark J. Levis
Johns Hopkins Sidney Kimmel Cancer Center, Baltimore, MD, United States
Feng Wang
UT MD Anderson Cancer Center, Houston, TX, United States
Jessica K. Altman
Northwestern Medicine, Chicago, IL, United States
from AACR Annual Meeting 2019 on April 1, 2019 1:00 PM-2:45 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 6 of 6